Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.

AIM To study the prognostic factors for intrahepatic cholangiocarcinoma (ICC) and evaluate the impact of chronic hepatitis B virus (HBV) infection on survival rate of ICC patients. METHODS A total of 155 ICC patients who underwent macroscopic curative resections (R0 and R1) were enrolled in this retrospective study and divided into group A with HBV infection and group B without HBV infection according to their chronic HBV infection, represented by positive hepatitis B surface antigen (HBsAg) in serum or in liver tissue. Clinicopathological characteristics and survival rate of the patients were evaluated. RESULTS All patients underwent anatomical resection. Their 1- and 3-year survival rates were 60.6% and 32.1%, respectively. Multivariate analyses revealed that HBV infection, hepatolithiasis, microscopic satellite lesion, and lymphatic metastasis were the independent prognostic factors for the survival rate of ICC patients. The median disease-free survival time of the patients was 5.0 mo. The number of tumors, microscopic satellite lesion, and vascular invasion were the independent prognostic factors for the disease-free survival rate of the patients. The prognostic factors affecting the survival rate of ICC patients with HBV infection and those without HBV infection were not completely consistent. Alkaline phosphatase > 119 U/L, microscopic satellite lesion, vascular invasion, and lymphatic metastasis were the independent factors for the patients with HBV infection, while r-glutamyltransferase > 64 U/L, microscopic satellite lesion, and poor tumor differentiation were the independent factors for the patients without HBV infection. CONCLUSION HBV infection is a valuable clinical factor for predicting tumor invasiveness and clinical outcome of ICC patients. ICC patients with HBV infection should be distinguished from those without HBV infection because they have different clinicopathological characteristics, prognostic factors and outcomes after surgical resection.

[1]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[2]  Hao Wang,et al.  Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. , 2010, European journal of cancer.

[3]  Feng Xie,et al.  Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. , 2009, World journal of gastroenterology.

[4]  J. Chung,et al.  The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival , 2009, Annals of Surgical Oncology.

[5]  C. H. Lee,et al.  Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma , 2009, British Journal of Cancer.

[6]  H. El‐Serag,et al.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population‐based study of U.S. veterans , 2009, Hepatology.

[7]  Jiamei Yang,et al.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. , 2008, World journal of gastroenterology.

[8]  H. Ojima,et al.  Clinical impact of the surgical margin status in hepatectomy for solitary mass‐forming type intrahepatic cholangiocarcinoma without lymph node metastases , 2007, Journal of surgical oncology.

[9]  A. Dennison,et al.  Prognostic molecular markers in hepatocellular carcinoma: a systematic review. , 2007, European journal of cancer.

[10]  M. Mihara,et al.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery , 2006, Journal of Gastroenterology.

[11]  E. Lesaffre,et al.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.

[12]  G. Tiberio,et al.  Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications , 2006, Annals of surgery.

[13]  S. Kubo,et al.  Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. , 2005, Journal of hepato-biliary-pancreatic surgery.

[14]  Y. Jan,et al.  Clinicopathological Factors Predicting Long-term Overall Survival after Hepatectomy for Peripheral Cholangiocarcinoma , 2005, World Journal of Surgery.

[15]  S. Todo,et al.  Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma , 2005, World Journal of Surgery.

[16]  Y. Jan,et al.  Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. , 2005, World journal of gastroenterology.

[17]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[18]  H. Goike,et al.  Clinical utility of cytokeratins as tumor markers. , 2004, Clinical biochemistry.

[19]  T. Hwang,et al.  Hepatic Resection of the Intraductal Papillary Type of Peripheral Cholangiocarcinoma , 2004, Annals of Surgical Oncology.

[20]  J. Furui,et al.  An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma , 2004, The British journal of surgery.

[21]  Rong Zeng,et al.  From Proteomic Analysis to Clinical Significance , 2004, Molecular & Cellular Proteomics.

[22]  S. Kubo,et al.  Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence , 2003, Cancer science.

[23]  F. Miura,et al.  Aggressive Surgical Resection for Hilar-invasive and Peripheral Intrahepatic Cholangiocarcinoma , 2003, World Journal of Surgery.

[24]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[25]  M. Miyazaki,et al.  Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival , 2002, The British journal of surgery.

[26]  M. Miyazaki,et al.  Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology , 2002, Journal of gastroenterology and hepatology.

[27]  P. Watanapa,et al.  Liver fluke‐associated cholangiocarcinoma , 2002, The British journal of surgery.

[28]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[29]  A. Bergquist,et al.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. , 2002, Journal of hepatology.

[30]  K. Hanazaki,et al.  Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. , 2002, Hepato-gastroenterology.

[31]  W. Jarnagin,et al.  Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. , 2001, Journal of the American College of Surgeons.

[32]  Nandita Ghosh,et al.  Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma , 2001, Diseases of the colon and rectum.

[33]  C. Cheung,et al.  Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma , 2001, Modern Pathology.

[34]  P. de Groen.  Cholangiocarcinoma in primary sclerosing cholangitis: Who is at risk and how do we screen? , 2000, Hepatology.

[35]  G. Gores,et al.  The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[36]  Y. Morioka,et al.  Postoperative Recurrence of Hepatocellular Carcinoma , 1990, Annals of surgery.

[37]  S. Sanes,et al.  Primary Carcinoma of the Liver: Cholangioma in Hepatolithiasis. , 1942, The American journal of pathology.